Explanation by the Board of Directors that this Transaction Complies with Articles 18, 21 of the 'Measures for Continuous Supervision of Listed Companies on the Growth Enterprise Market (Trial)' and Article 8 of the 'Review Rules for Major Asset Restructuring of Listed Companies on the Shenzhen Stock Exchange'